GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Total Receivables

Arch Biopartners (TSXV:ARCH) Total Receivables : C$1.74 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Total Receivables?

Arch Biopartners's Total Receivables for the quarter that ended in Mar. 2024 was C$1.74 Mil.

Arch Biopartners Total Receivables Historical Data

The historical data trend for Arch Biopartners's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Total Receivables Chart

Arch Biopartners Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.06 2.20 0.09 0.30

Arch Biopartners Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.97 0.01 0.30 0.31 1.74

Arch Biopartners Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Arch Biopartners Total Receivables Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Total Receivables
Comparable Companies
XCNQ:ACOG TSX:MDNA TSXV:COV TSX:ONC XCNQ:METX TSX:MSCL TSX:EPRX TSX:TH TSX:SVA TSXV:NGEN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
ACHFF:USA
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Website
https://www.archbiopartners.com
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.